In the U.S, 1 in 3 adults have nonalcoholic fatty liver disease (NAFLD) – and it is the No. 1 reason women are added to the liver transplant list. In this MedBlog, Thomas Kerr, M.D., Ph.D., discusses why NAFLD is rampant and how it can be prevented and treated.
Thomas Kerr, M.D., Ph.D.
October 14, 2020